TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
JRS Pharma Oy
Closing information (x1000 EUR)
Closing information | 2016/12 | 2015/12 | 2014/12 |
Turnover |
10,908
|
11,349
|
11,148 |
Financial expenses |
2
![]() |
2
|
3 |
Earnings before taxes |
2,207
|
2,113
|
1,749 |
Total assets |
6,614
|
5,847
|
6,965 |
Current assets |
3,068
|
2,150
|
3,276 |
Current liabilities |
1,463
|
1,559
|
1,464 |
Equity capital |
5,086
|
4,197
|
5,396 |
- share capital |
168
![]() |
168
![]() |
168 |
Financial ratios
Fiscal year | 2016/12 | 2015/12 | 2014/12 |
Solvency |
76.9%
|
71.8%
|
77.5% |
Turnover per employee | |||
Profit as a percentage of turnover |
20.2%
|
18.6%
|
15.7% |
Return on assets (ROA) |
33.4%
|
36.2%
|
25.2% |
Current ratio |
209.7%
|
137.9%
|
223.8% |
Return on equity (ROE) |
43.4%
|
50.3%
|
32.4% |
Change turnover |
-441
|
201
|
1,131 |
Change turnover % |
-4%
|
2%
|
11% |
Chg. No. of employees | |||
Chg. No. of employees % |
Total value of public sale
Fiscal year | 2016/12 | 2015/12 | 2014/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.